JS
Schedule 13G filing
JP Sailing Capital Ltd disclosed a 9.9% stake in NXTC
JP Sailing Capital Ltd reported owning 9.9% of NextCure, Inc. (NXTC) (455,001 shares) in a Schedule 13G filed Oct 20, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More NXTC insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.